Home
>
US Stocks
>
SIGA Technologies Inc
SIGA Technologies Inc
SIGA

SIGA Technologies Inc (SIGA)

$7.0410.69%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7
Today Low/High
7 / 7.1
52 Week Low/High
$5.66 / $7.85
P/E ratio
11.03
Market Cap
$481.99M

Company Details

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Its lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a stockpile of 1.7 million oral courses in the Strategic National Stockpile under Project BioShield. The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox on July 13, 2018. In September 2018, SIGA signed a contract with Biomedical Advanced Research and Development Authority (BARDA) for additional procurement and development related to both oral and intravenous formulations of TPOXX.
Organisation
SIGA Technologies Inc
Employees
42
Industry
Health Technology

Discover more

Frequently Asked Questions

What is SIGA Technologies Inc (SIGA) share price today?

Can Indians buy SIGA Technologies Inc (SIGA) shares?

How can I buy SIGA Technologies Inc (SIGA) shares from India?

Can Fractional shares of SIGA Technologies Inc (SIGA) be purchased?

What are the documents required to start investing in SIGA Technologies Inc (SIGA) stocks?

We are a SEBI registered investement advisor